Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

LENZ Therapeutics (LENZ) Other Gross PP&E Adjustments (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $810000.0 as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 230.86% to $810000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $810000.0 through Dec 2025, up 230.86% year-over-year, with the annual reading at $810000.0 for FY2025, 230.86% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $810000.0 at LENZ Therapeutics, up from -$847000.0 in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $32.8 million in Q1 2023, with the low at -$1.7 million in Q2 2024.
  • Average Other Gross PP&E Adjustments over 4 years is $4.1 million, with a median of -$1000.0 recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments soared 5889.21% in 2023, then crashed 153200.0% in 2024.
  • Over 4 years, Other Gross PP&E Adjustments stood at $18.6 million in 2022, then crashed by 100.01% to -$1000.0 in 2023, then plummeted by 61800.0% to -$619000.0 in 2024, then skyrocketed by 230.86% to $810000.0 in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $810000.0, -$847000.0, and -$959000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.